VentriPoint Diagnostics Ltd.
VPTDF
$0.123
$0.021821.54%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 111.16% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 111.16% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 111.16% | -- | |||
| SG&A Expenses | -11.04% | 13.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.68% | 18.68% | |||
| Operating Income | 13.38% | -16.11% | |||
| Income Before Tax | 11.57% | -17.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.57% | -17.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.57% | -17.58% | |||
| EBIT | 13.38% | -16.11% | |||
| EBITDA | 13.35% | -16.17% | |||
| EPS Basic | 12.12% | -17.86% | |||
| Normalized Basic EPS | 12.20% | -17.14% | |||
| EPS Diluted | 12.12% | -17.86% | |||
| Normalized Diluted EPS | 12.20% | -17.14% | |||
| Average Basic Shares Outstanding | 0.19% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
